These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

187 related articles for article (PubMed ID: 37640958)

  • 41. Muscle hypertrophic effect of inhaled beta
    Jessen S; Baasch-Skytte T; Onslev J; Eibye K; Backer V; Bangsbo J; Hostrup M
    J Physiol; 2022 May; 600(10):2345-2357. PubMed ID: 35218559
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Formoterol concentrations in blood and urine: the World Anti-Doping Agency 2012 regulations.
    Eibye K; Elers J; Pedersen L; Henninge J; Hemmersbach P; Dalhoff K; Backer V
    Med Sci Sports Exerc; 2013 Jan; 45(1):16-22. PubMed ID: 22843108
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
    Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
    Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Pharmacogenetic Effects of Inhaled Salbutamol on 10-km Time Trial Performance in Competitive Male and Female Cyclists.
    Koch S; MacInnis MJ; Rupert JL; Sporer BC; Koehle MS
    Clin J Sport Med; 2016 Mar; 26(2):145-51. PubMed ID: 25894531
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The Effect of 1600 μg Inhaled Salbutamol Administration on 30 m Sprint Performance Pre and Post a Yo-Yo Intermittent Running Test in Football Players.
    Merlini M; Beato M; Marcora S; Dickinson J
    J Sports Sci Med; 2019 Dec; 18(4):716-721. PubMed ID: 31827356
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Pharmacokinetics of salmeterol and its main metabolite α-hydroxysalmeterol after acute and chronic dry powder inhalation in exercising endurance-trained men: Implications for doping control.
    Jessen S; Becker V; Rzeppa S; Backer V; Bengtsen KH; Hullstein I; Dehnes Y; Hostrup M
    Drug Test Anal; 2021 Apr; 13(4):747-761. PubMed ID: 33210444
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Dose response of inhaled salbutamol on exercise performance and urine concentrations.
    Sporer BC; Sheel AW; McKenzie DC
    Med Sci Sports Exerc; 2008 Jan; 40(1):149-57. PubMed ID: 18091010
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Effects of acute and 2-week administration of oral salbutamol on exercise performance and muscle strength in athletes.
    Hostrup M; Kalsen A; Auchenberg M; Bangsbo J; Backer V
    Scand J Med Sci Sports; 2016 Jan; 26(1):8-16. PubMed ID: 25077918
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of short-term oral salbutamol administration on exercise endurance and metabolism.
    Collomp K; Candau R; Lasne F; Labsy Z; Préfaut C; De Ceaurriz J
    J Appl Physiol (1985); 2000 Aug; 89(2):430-6. PubMed ID: 10926623
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A bolus of inhaled budesonide rapidly reverses airway subsensitivity and beta2-adrenoceptor down-regulation after regular inhaled formoterol.
    Aziz I; Lipworth BJ
    Chest; 1999 Mar; 115(3):623-8. PubMed ID: 10084466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The influence of exercise and dehydration on the urine concentrations of salbutamol after inhaled administration of 1600 µg salbutamol as a single dose in relation to doping analysis.
    Haase CB; Backer V; Kalsen A; Rzeppa S; Hemmersbach P; Hostrup M
    Drug Test Anal; 2016 Jul; 8(7):613-20. PubMed ID: 26044066
    [TBL] [Abstract][Full Text] [Related]  

  • 52. High-Dose Inhaled Salbutamol Does Not Improve 10-km Cycling Time Trial Performance.
    Koch S; Ahn JR; Koehle MS
    Med Sci Sports Exerc; 2015 Nov; 47(11):2373-9. PubMed ID: 25856682
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of formoterol on endurance performance in athletes at an ambient temperature of -20 degrees C.
    Tjørhom A; Riiser A; Carlsen KH
    Scand J Med Sci Sports; 2007 Dec; 17(6):628-35. PubMed ID: 17316372
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Effects of Acute Salbutamol Intake on Peripheral and Central Fatigue in Trained Men.
    Laurent J; Guinot M; LE Roux Mallouf T; Marillier M; Larribaut J; Verges S
    Med Sci Sports Exerc; 2018 Jun; 50(6):1267-1276. PubMed ID: 29389835
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effects of salbutamol on the contractile properties of human skeletal muscle before and after fatigue.
    Crivelli G; Millet GP; Gremion G; Borrani F
    Acta Physiol (Oxf); 2011 Oct; 203(2):311-20. PubMed ID: 21477068
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The salmeterol anomaly and the need for a urine threshold.
    Jacobson GA; Hostrup M
    Drug Test Anal; 2022 Jun; 14(6):997-1003. PubMed ID: 32314556
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Beyond bronchodilation: Illuminating the performance benefits of inhaled beta
    Hostrup M; Jessen S
    Scand J Med Sci Sports; 2024 Jan; 34(1):e14567. PubMed ID: 38268072
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Formoterol: a review of its use in chronic obstructive pulmonary disease.
    Cheer SM; Scott LJ
    Am J Respir Med; 2002; 1(4):285-300. PubMed ID: 14720051
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy.
    Lipworth BJ; Hall IP; Aziz I; Tan KS; Wheatley A
    Clin Sci (Lond); 1999 Mar; 96(3):253-9. PubMed ID: 10029561
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Comparative trough effects of formoterol and salmeterol on lymphocyte beta2-adrenoceptor--regulation and bronchodilatation.
    Aziz I; McFarlane LC; Lipworth BJ
    Eur J Clin Pharmacol; 1999 Aug; 55(6):431-6. PubMed ID: 10492055
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.